Karyopharm Therapeutics | Utile Per Azione

Prezzo Delle Azioni
9.23
Cambio Giornaliero
-0.36 -3.75%
Mensile
46.51%
Annuale
44.90%
Q1 Previsione
9.12




Eps Cambiamento Data
AbbVie USD 2.71 0.85 2025-12
Abbott USD 1.5 0.2 2025-12
Amgen USD 5.29 0.35 2025-12
AstraZeneca USD 2.12 0.26 2025-12
BioCryst Pharmaceuticals USD -0.13 0.06 2024-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Incyte USD 1.8 0.46 2025-12
J&J USD 2.46 0.34 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
MacroGenics USD 0.27 0.84 2025-09
Merck USD 2.04 0.54 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Novartis USD 2.04 0.38 2025-09
Novartis USD 2.02 0.04 2025-09
Pfizer USD 0.66 0.21 2025-12
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Takeda JPY 65.74 73.57 2025-12
Tectonic Therapeutic USD -1.02 0.05 2025-09
TG Therapeutics USD 0.14 2.29 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Xencor USD -0.09 0.01 2025-12


Karyopharm Therapeutics Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.